Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edecio Cunha-Neto

Showing results (121-130 of 147) with videos related to

Pageof 15
Sort By:
Plos Neglected Tropical Diseases|December 22, 2020
miRNAs may play a major role in the control of gene expression in key pathobiological processes in Chagas disease cardiomyopathyLaurie Laugier, Ludmila Rodrigues Pinto Ferreira, Frederico Moraes Ferreira, et al.
Plos Neglected Tropical Diseases|November 15, 2012
Myocardial chemokine expression and intensity of myocarditis in Chagas cardiomyopathy are controlled by polymorphisms in CXCL9 and CXCL10Luciana Gabriel Nogueira, Ronaldo Honorato Barros Santos, Barbara Maria Ianni, et al.
Frontiers in Immunology|June 8, 2023
Cognitive impairment in long-COVID and its association with persistent dysregulation in inflammatory markersRodolfo Furlan Damiano, Cristiana Castanho de Almeida Rocca, Antonio de Pádua Serafim, et al.
Scientific Reports|February 7, 2023
MiRNA-30d and miR-770-5p as potential clinical risk predictors of Vasoplegic Syndrome in Patients undergoing on-pump coronary artery bypass graftingOmar Asdrúbal Vilca Mejia, Renato Cesar de Souza, Aritania S Santos, et al.
BMC Infectious Diseases|December 17, 2013
Genetic susceptibility to Chagas disease cardiomyopathy: involvement of several genes of the innate immunity and chemokine-dependent migration pathwaysAmanda Farage Frade, Cristina Wide Pissetti, Barbara Maria Ianni, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 10, 2023
Pentoxifylline reduces inflammation and prevents myocardial perfusion derangements in experimental chronic Chagas' cardiomyopathyDenise Mayumi Tanaka, Camila Godoy Fabricio, José A Marin-Neto, et al.
Nature Communications|April 19, 2018
Canonical PI3Kγ signaling in myeloid cells restricts Trypanosoma cruzi infection and dampens chagasic myocarditisMaria C Silva, Marcela Davoli-Ferreira, Tiago S Medina, et al.
Frontiers in Immunology|March 18, 2022
Reduced T Cell and Antibody Responses to Inactivated Coronavirus Vaccine Among Individuals Above 55 Years OldGiuliana X Medeiros, Greyce Luri Sasahara, Jhosiene Y Magawa, et al.
Clinical Immunology (Orlando, Fla.)|April 4, 2025
Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil: Differential neutralization of SARS-CoV-2 omicron variantsIsabela Pazotti Daher, Bianca da Silva Almeida, Guilherme Antonio de Souza-Silva, et al.
Frontiers in Immunology|August 1, 2025
Adjuvant combination and antigen multimerization shape neutralizing antibody and T cell responses to a SARS-CoV-2 RBD subunit vaccineJoão Pedro da Silva Nunes, Mariângela de Oliveira Silva, Juliana de Souza Apostolico, et al.
Pageof 15

Showing results (121-130 of 147) with videos related to

Sort By:
Pageof 15
Plos Neglected Tropical Diseases|December 22, 2020
miRNAs may play a major role in the control of gene expression in key pathobiological processes in Chagas disease cardiomyopathyLaurie Laugier, Ludmila Rodrigues Pinto Ferreira, Frederico Moraes Ferreira, et al.
Plos Neglected Tropical Diseases|November 15, 2012
Myocardial chemokine expression and intensity of myocarditis in Chagas cardiomyopathy are controlled by polymorphisms in CXCL9 and CXCL10Luciana Gabriel Nogueira, Ronaldo Honorato Barros Santos, Barbara Maria Ianni, et al.
Frontiers in Immunology|June 8, 2023
Cognitive impairment in long-COVID and its association with persistent dysregulation in inflammatory markersRodolfo Furlan Damiano, Cristiana Castanho de Almeida Rocca, Antonio de Pádua Serafim, et al.
Scientific Reports|February 7, 2023
MiRNA-30d and miR-770-5p as potential clinical risk predictors of Vasoplegic Syndrome in Patients undergoing on-pump coronary artery bypass graftingOmar Asdrúbal Vilca Mejia, Renato Cesar de Souza, Aritania S Santos, et al.
BMC Infectious Diseases|December 17, 2013
Genetic susceptibility to Chagas disease cardiomyopathy: involvement of several genes of the innate immunity and chemokine-dependent migration pathwaysAmanda Farage Frade, Cristina Wide Pissetti, Barbara Maria Ianni, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 10, 2023
Pentoxifylline reduces inflammation and prevents myocardial perfusion derangements in experimental chronic Chagas' cardiomyopathyDenise Mayumi Tanaka, Camila Godoy Fabricio, José A Marin-Neto, et al.
Nature Communications|April 19, 2018
Canonical PI3Kγ signaling in myeloid cells restricts Trypanosoma cruzi infection and dampens chagasic myocarditisMaria C Silva, Marcela Davoli-Ferreira, Tiago S Medina, et al.
Frontiers in Immunology|March 18, 2022
Reduced T Cell and Antibody Responses to Inactivated Coronavirus Vaccine Among Individuals Above 55 Years OldGiuliana X Medeiros, Greyce Luri Sasahara, Jhosiene Y Magawa, et al.
Clinical Immunology (Orlando, Fla.)|April 4, 2025
Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil: Differential neutralization of SARS-CoV-2 omicron variantsIsabela Pazotti Daher, Bianca da Silva Almeida, Guilherme Antonio de Souza-Silva, et al.
Frontiers in Immunology|August 1, 2025
Adjuvant combination and antigen multimerization shape neutralizing antibody and T cell responses to a SARS-CoV-2 RBD subunit vaccineJoão Pedro da Silva Nunes, Mariângela de Oliveira Silva, Juliana de Souza Apostolico, et al.
Pageof 15